Screener
MBX Biosciences, Inc. MBX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210593
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Purchases of marketable securities | (154,160) | (58,894) |
| Maturities of marketable securities | 57,500 | 57,150 |
| Call redemptions of marketable securities | — | 5,000 |
| Net cash (used in) provided by investing activities | (97,097) | 3,226 |
| Cash flows from financing activities: | ||
| Proceeds from at-the-market offering, net of underwriting discounts and commissions | 85,371 | — |
| Proceeds from exercise of common stock options | 2,442 | 4 |
| Payments related to offering costs | (378) | — |
Item 1. Financial Statements.
FAQ
- What is MBX Biosciences, Inc.'s investing cash flow?
- MBX Biosciences, Inc. (MBX) reported investing cash flow of -$97.1M in Q1 2026.
- How has MBX Biosciences, Inc.'s investing cash flow changed year-over-year?
- MBX Biosciences, Inc.'s investing cash flow decreased by 3109.8% year-over-year, from $3.23M to -$97.1M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about MBX Biosciences, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude